Label Changes for:
Stromectol (ivermectin) 3 mg Tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009
The following adverse reactions have been reported since the drug was registered overseas:
- Onchocerciasis: Conjunctival hemorrhage
- All Indications: hepatitis